Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis

We have reported previously that dihydropyridine-type calcium-channel antagonists (DTCCA) such as nifedipine decrease plasma markers of oxidative stress damage in systemic sclerosis (SSc). To clarify the cellular basis of these beneficial effects, we investigated the effects in vivo and in vitro of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Allanore, Yannick, Borderie, Didier, Périanin, Axel, Lemaréchal, Hervé, Ekindjian, Ohvanesse Garabed, Kahan, André
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2005
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1064885/
https://ncbi.nlm.nih.gov/pubmed/15642147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1457
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados